FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Real-time BOERSE MUENCHEN 10:25:02 2024-05-23 EDT | ||
| 6.84 EUR | -10.47% |
|
| Current month | +12.52% | ||
| 1 month | +12.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 6.84 | -10.47% |
| 24-05-22 | 7.64 | -2.55% |
| 24-05-21 | 7.84 | -3.33% |
| 24-05-20 | 8.11 | -0.73% |
| 24-05-17 | 8.17 | +3.94% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 10:25 am
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG3E3Q |
| ISIN | DE000GG3E3Q1 |
| Date issued | 2024-02-02 |
| Strike | 818.8 p |
| Maturity | Unlimited |
| Parity | 0.3 : 1 |
| Emission price | 13.55 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.2 € |
|---|---|
| Lowest since issue | 5.99 € |
| Spread | 0.2 € |
| Spread % | 2.95% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92
USD
Average target price
16.31
USD
Spread / Average Target
+26.28%
- Stock Market
- Certificates
- Certificat
